You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for SELENIOUS ACID


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SELENIOUS ACID

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 211176_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 229857_ALDRICH ⤷  Get Started Free
MP Biomedicals ⤷  Get Started Free 218280 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Selenious Acid

Last updated: July 31, 2025

Introduction

Selenious acid (H₂SeO₃) serves as a pivotal active pharmaceutical ingredient (API) utilized in several therapeutic applications, primarily as an antioxidant, a selenium supplement, and in the manufacturing of diagnostic reagents. Its demand is driven by the expanding nutraceutical sector, pharmaceutical formulations, and specialty chemicals. Identifying reliable bulk sources for selenious acid is crucial for pharmaceutical companies, contract manufacturing organizations (CMOs), and chemical suppliers aiming to ensure high-quality, cost-effective procurement. This report analyzes current global sources, market dynamics, and key suppliers involved in the bulk supply of selenious acid.

1. Overview of Selenious Acid and Market Demand

Selenious acid is a water-soluble compound integral to selenium supplementation therapies, especially in regions with selenium-deficient soils. The compound's antiviral, antioxidant, and immune-boosting properties make it attractive in pharmaceutical formulations. The global selenium supplement market, projected to reach USD 1.41 billion by 2025, underpins the demand for high-purity selenious acid [[1]].

Pharmaceutical-grade selenious acid must meet stringent purity standards, typically exceeding 99%. Regulatory agencies like the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) set rigorous guidelines for APIs, emphasizing quality, traceability, and compliance.

2. Primary Sources and Manufacturing Countries

2.1. China

China remains the dominant supplier of selenium compounds, including selenious acid, owing to its extensive selenium-rich mineral resources and well-developed chemical manufacturing infrastructure. Major Chinese chemical producers export bulk quantities of selenious acid to global markets [[2]].

Key Chinese manufacturers include:

  • Linyin Chemical Industry Co., Ltd.: Specializes in selenium compounds, including high-purity selenious acid, with GMP-certified facilities.

  • Shandong Canning Corporation: Offers selenium supplements and derivatives, including bulk selenious acid meeting pharmaceutical standards.

  • Shaanxi Top Pharm Chemical Co.: Supplies pharmaceutical-grade selenious acid, primarily to North American and European markets.

2.2. Europe

European chemical and pharmaceutical firms manufacture and supply high-purity selenious acid, leveraging advanced purification and quality control techniques. Notable sources include:

  • BASF SE (Germany): One of the global leaders in specialty chemicals, BASF produces selenium compounds with the necessary pharmaceutical-grade specifications.

  • Vinci Antioxidant (France): Supplies selenium-based antioxidants and intermediates, including selenious acid for pharmaceutical applications.

2.3. United States

In the U.S., specialized chemical suppliers and contract manufacturers produce selenium compounds, primarily for pharmaceutical and nutraceutical sectors.

  • American Elements (USA): Offers high-purity selenious acid (multi-gram to kilogram quantities) suitable for pharma and research use.

  • Spectrum Chemical Manufacturing Corp.: Supplies selenium compounds, including pharmaceutical-grade selenious acid, with comprehensive quality certificates.

2.4. India

India's chemical manufacturing sector has expanded its selenium compound portfolio, serving domestic and international markets.

  • Nexelis (India): Provides bulk selenium compounds, including selenious acid, aligned with pharmaceutical standards.

  • Venus Organic Chemicals: Offers selenium derivatives, with an emphasis on export-quality selenious acid.

3. Key Considerations for Bulk Selenious Acid Procurement

3.1. Quality Standards

Ensuring compliance with pharmacopeial specifications (USP, EP, or JP) is paramount. Suppliers should furnish Certificates of Analysis (CoA), Batch Production Records, and purity data confirming ≥99% purity.

3.2. Regulatory Compliance

Suppliers must adhere to Good Manufacturing Practices (GMP) and provide necessary documentation for regulatory submissions. Traceability and quality assurance systems are critical.

3.3. Pricing and Lead Times

Pricing varies significantly based on purity, quantity, supplier origin, and geopolitical considerations. Chinese suppliers often offer competitive prices but may face logistical and regulatory hurdles for export, especially during shifts in trade policies.

3.4. Supply Chain Stability

Reliability and the capacity to fulfill large-scale orders are vital. Establishing strategic partnerships with multiple suppliers mitigates supply disruptions.

4. Market Dynamics and Trends

  • Growing Demand: The nutraceutical sector's growth amplifies demand for high-quality selenious acid as a selenium supplement.

  • Regulatory Evolution: Stricter quality requirements are compelling suppliers to upgrade manufacturing standards.

  • Supply Chain Diversification: Companies increasingly seek diversified sourcing to avoid over-reliance on Chinese suppliers, integrating European, American, and Indian sources.

  • Environmental and Ethical Considerations: Sourcing from environmentally conscious and ethically compliant manufacturers influences procurement decisions.

5. Challenges and Opportunities

5.1. Challenges

  • Quality Variability: Inconsistent purity levels and impurities can compromise product efficacy and regulatory approval.

  • Trade and Tariffs: Geopolitical tensions may impact import/export of selenium compounds.

  • Environmental Regulations: Stringent environmental policies in manufacturing regions can influence production capacity.

5.2. Opportunities

  • Advanced Purification Technologies: Suppliers investing in purification and quality control enhance product reliability.

  • Custom Synthesis and Formulation: Tailored sourcing solutions enable pharmaceutical firms to meet specific formulation needs.

  • Emerging Markets: Expansion into markets like Southeast Asia presents new sourcing avenues.

Conclusion

Selenious acid remains a critical API with growing applications across pharmaceuticals and nutraceuticals. China dominates the bulk supply landscape, offering cost-effective, high-purity materials. Europe and the United States focus on premium quality, adhering to stringent regulatory standards. India presents an emerging source with increasing production capacity.

Procurement strategies should prioritize quality assurance, regulatory compliance, and supply chain robustness. Collaborative relationships with diverse suppliers can optimize costs and minimize risks, ensuring consistent supply for pharmaceutical manufacturing.


Key Takeaways

  • Global sourcing of selenious acid spans China, Europe, the US, and India, with China leading in volume and cost competitiveness.

  • Quality and regulatory compliance are non-negotiable; suppliers must meet pharmacopeial standards, provide extensive documentation, and adhere to GMP.

  • Supply chain diversification reduces dependency risk, especially amidst geopolitical changes affecting Chinese exports.

  • Emerging markets and technological innovations present new opportunities for sourcing high-quality selenious acid.

  • Price, purity, and delivery timelines should be balanced to align with project requirements and regulatory timelines.


FAQs

1. What purity levels are standard for pharmaceutical-grade selenious acid?
Pharmaceutical-grade selenious acid typically exceeds 99% purity, conforming to pharmacopeial standards like USP or EP, to ensure safety and efficacy.

2. Which countries are the leading suppliers of bulk selenious acid?
China leads in volume and cost efficiency; Europe and the US focus on high purity and regulatory compliance; India is emerging as a significant producer.

3. What regulatory challenges exist when sourcing selenious acid internationally?
Regulatory challenges include ensuring compliance with GMP, obtaining necessary import licenses, and meeting country-specific quality standards.

4. How does price variability influence procurement strategies?
Lower-cost Chinese suppliers often offer competitive pricing, but importing costs, quality assurance, and regulatory hurdles may offset savings. Conversely, suppliers in Europe and the US may command higher prices but provide higher assurance levels.

5. What future trends will impact the supply of selenious acid?
Increasing demand for natural and nutraceutical selenium sources, stricter regulations, innovations in purification technology, and geopolitical considerations will shape the supply landscape.


Sources

[1] MarketsandMarkets. “Selenium Market by Source, Application, and Region – Global Forecast to 2025.”
[2] Global Chemical Market Insights. “Selenium Compounds: Production and Supply Dynamics.”

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.